Category: Observations
-
Ahead of ESMO 2026: What the Next Biomarkers Need from Diagnostic Partnerships
Ahead of ESMO 2026: why diagnostic partnerships must carry testing beyond approval into routine care, so no eligible patient misses the best treatment.
-
Diagnostics is changing: where is the industry going?
Reflections from APIFARMA on the future of diagnostics: deeper biological insight, measurement closer to people, smarter interpretation and connected information—and the market development, commercial skills and partnerships needed to deliver their value.
-
Diagnostic Informatics: the conversation is changing faster than the market
Cloud computing and AI are expanding what can be done with diagnostic information. But Persodia’s reconstruction of the 2025 market finds that around 72% of today’s Diagnostic Informatics revenue still lies in Laboratory Operations. Diagnostic Informatics has rarely attracted as much attention as it does today. Cloud computing has changed what can be connected, deployed…
-
The Refining Layer: Where Value Moves as Diagnostics Becomes Computational
Field observation drawing on D4 Salzburg 2026 “Data is the new gold” is repeated so often in healthcare that it has stopped carrying an argument. It also hides the part that matters commercially. Gold underground is not wealth. It becomes wealth through extraction, refining and the infrastructure that makes it tradable — and most of…
-
When Partnership Is Critical, the Team Makes the Difference
What the Spanish diagnostics market shows about competing through complex solutions In complex healthcare markets, the best product is increasingly not enough. Customers are being asked to deliver more clinical value with constrained people and budgets, and the solutions they need now combine technology, workflow, service, supply, integration — and, often, capabilities that sit across…
-
The Triumph of Specialists
This year (at ADLM) I had the chance to verify a old thesis about the role of Specialists in the expansion of diagnostics. Spot on! It came from looking at the market. Put all the specialist areas of diagnostics together and they add up to a remarkable part of the industry. Yet the story we…
-
A Land of Opportunity
Most of us grew up with the idea of America as the land of opportunity — a place where hard work could build a better future. I have arrived in Anaheim in something of that spirit. Next to Disney’s wonderland, I am more interested in the other one down the road. ADLM is a conference…
-
Merck Future Insight Prize 2026, Darmstadt
From “Hearing the Light” to Preventive Health Understanding The 2026 Merck Future Insight Prize focused on a provocative proposition: future healthcare may depend increasingly on the ability to observe biological change before symptoms, deterioration or clinical crisis make it visible. The prize was awarded to Professor Vasilis Ntziachristos for his pioneering work in optoacoustics, an…
-
5 Signals from HLTH Europe That Reveal Diagnostics’ Next Challenge
I attended HLTH Europe looking for signals about the future role of diagnostics in healthcare. AI dominated the agenda, but the most interesting observation was not AI itself. It was the convergence of five themes: Taken together, these conversations point to something larger than technology. Health intelligence is being built. Diagnostics is already part of…
-
Healthcare as Seen at HLTH Europe 2026
This Observation draws on HLTH Europe 2026 as a selective but useful view of where healthcare attention is moving. No conference represents the full reality of healthcare. Conferences highlight certain themes, attract particular audiences, and leave much of everyday clinical, operational, and institutional life outside the room. Even so, they can reveal where investment is…